购物车
- 全部删除
- 您的购物车当前为空
NF-κB-IN-19 (Compound 8) 是一种NF-κB抑制剂,通过NF-κB信号通路有效诱导肿瘤细胞DNA损伤,促进ROS生成,并诱导细胞自噬 (autophagy) 和凋亡 (apoptosis)。此外,它抑制VEGF和HIF-1α水平,并通过PI3K/AKT和STAT-3途径在肿瘤细胞中展示抗增殖活性。NF-κB-IN-19 有效克服顺铂耐药性,表现出抗肿瘤活性。
NF-κB-IN-19 (Compound 8) 是一种NF-κB抑制剂,通过NF-κB信号通路有效诱导肿瘤细胞DNA损伤,促进ROS生成,并诱导细胞自噬 (autophagy) 和凋亡 (apoptosis)。此外,它抑制VEGF和HIF-1α水平,并通过PI3K/AKT和STAT-3途径在肿瘤细胞中展示抗增殖活性。NF-κB-IN-19 有效克服顺铂耐药性,表现出抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 期货 | |
50 mg | 待询 | 期货 |
产品描述 | NF-κB-IN-19 (Compound 8) is an NF-κB inhibitor. It effectively induces DNA damage in tumor cells through the NF-κB signaling pathway and promotes the production of reactive oxygen species (ROS), as well as induces autophagy and apoptosis. Additionally, NF-κB-IN-19 inhibits levels of VEGF and HIF-1α, exerting antiproliferative effects in tumor cells through the PI3K/AKT and STAT-3 pathways. It is also effective in overcoming cisplatin resistance and exhibits antitumor activity. |
分子量 | 759.92 |
分子式 | C24H26Cl3F2N3O4Pt |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容